Skip to main content
大唐药业 logo

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2024-03-19 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

http://www.nmdt.com.cn/

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
董事会审计委员会2023 年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a report from the Board Audit Committee of Inner Mongolia Datang Pharmaceutical Co., Ltd. for the year 2023. It details the committee's activities, including meetings held, review of financial reports, supervision of external auditors, internal audit guidance, and overall evaluation of the committee's performance during the year. The content focuses on the audit committee's duties and oversight related to the company's financial reporting and internal controls, rather than presenting the full audited financial statements or the annual report itself. The document length is 2382 characters, which is relatively short and more consistent with a committee report rather than a full Annual Report (10-K) or Audit Report (AR). It is not an announcement or certification but a substantive report on audit committee activities. Therefore, the best fitting category is Audit Report / Information (AR), as it is a standalone audit-related report detailing audit committee activities and oversight for the year 2023. FY 2023
2024-03-19 Chinese
大华会计师事务所（特殊普通合伙）关于内蒙古大唐药业股份有限公司募集资金存放与使用情况鉴证报告
Regulatory Filings
2024-03-19 Chinese
审计委员会对会计师事务所履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a report from the Audit Committee regarding the supervision of the accounting firm (auditor) for the fiscal year 2023. It discusses the auditor's qualifications, the audit process, and the audit committee's evaluation of the auditor's performance. It includes details about the auditor's independence, audit scope, and communication with management. The document does not contain the full audited financial statements or the full annual report but is a standalone report on the audit process and auditor oversight. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and related supervisory information. The document length is 2016 characters, which is relatively short but contains substantive content about the audit committee's oversight rather than just an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2023
2024-03-19 Chinese
2023年度审计报告
Regulatory Filings
2024-03-19 Chinese
内蒙古上都律师事务所关于内蒙古大唐药业股份有限公司2020年第一期股权激励计划第三个解除限售期解限售条件未成就暨回购注销部分限制性股票之法律意见书
Regulatory Filings
2024-03-19 Chinese
2023年年度报告
Annual Report Classification · 100% confidence The document is titled "内蒙古大唐药业股份有限公司 2023 年年度报告" which translates to "Inner Mongolia Grand Pharmaceutical Co., Ltd. 2023 Annual Report." It contains detailed financial data, including income statements, balance sheets, management discussion and analysis, company overview, accounting policies, and other comprehensive information typical of a full annual report. The document length is 15,000 characters, indicating a full report rather than a brief announcement. It includes audited financial statements and auditor's opinion, which are standard components of an annual report. Therefore, this document is classified as an Annual Report (10-K equivalent). FY 2023
2024-03-19 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.